BioSpace News Archive

American Senior Communities (ASC) recently broke the silence and rocked library goers with a surprise flash mob.

Liberty Health Sciences Inc. is pleased to announce that it has signed a licensing agreement with Isodiol International Inc.

Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis (OM), today announced positive results from its interim safety analysis as requested by FDA on patients from its Phase 2 clinical trial of AG013 for the treatment of OM.

Centene Corporation announced it will present at the Goldman Sachs 39th Annual Global Healthcare Conference.

Financing led by Aptar Pharma, with participation from existing investors Safeguard Scientifics, Social Capital, Hikma, 3M Ventures and SR One

Lycera Corp. announced presentations of the company’s novel immuno-oncology therapeutic candidate, LYC-55716, to take place during the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.

Eiger BioPharmaceuticals, Inc. announced that David Cory, President and CEO, will present a corporate update at Jefferies 2018 Global Healthcare Conference.

Planned Start of Clinical Program and Clearance of U.S. Food and Drug Administration Investigational New Drug Application Reflect Progress in Strategic Partnership with Legend Biotech

Genomic Health, Inc. announced that it will present at the Jefferies 2018 Global Healthcare Conference.

Weight Watchers International, Inc. (NYSE: WTW) (“WW”) is launching WW Good™, a global social impact campaign that aims to make health and wellness more accessible to all.